Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2011 18:03 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Financial Results for Third Quarter FY2011

MORRISVILLE, N.C., March 21, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
March 14, 2011 18:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Third Quarter FY2011 Financial Results Conference Call and Webcast

MORRISVILLE, N.C., March 14, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company plans to report third quarter fiscal year...
March 10, 2011 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Signs Agreement to Sell DERMACYTE Products to Mexican Sales and Distribution Company

MORRISVILLE, N.C., March 10, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has entered into an agreement with independently owned and...
March 02, 2011 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Receives U.S. Army Grant for Studies of Oxycyte(R), a Novel Traumatic Brain Injury Therapeutic for Combat Casualties

MORRISVILLE, N.C., March 2, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received a $2.075 million, two-year grant from the U.S....
January 28, 2011 00:30 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics and Hackensack University Medical Center Sign Research Contract Funded by the U.S. Department of Defense to Study Wound Healing Properties of Wundecyte(TM) Gel

DURHAM, N.C., Jan. 28, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SWX:OXBT) today announced it has signed a research contract with Hackensack University Medical Center (HUMC)...
January 12, 2011 11:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Signs Agreement to Sell DERMACYTE Products to Swiss Sales and Distribution Company

DURHAM, N.C. and ZURICH, Switzerland, Jan. 12, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced it has entered into an agreement with the newly formed,...
December 16, 2010 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics and Sarasota Medical Products Sign Binding Letter of Intent to Pursue Joint Research and Development in Chronic Ischemic Wound Care

DURHAM, N.C., Dec. 16, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) and privately held Sarasota Medical Products, Inc. (SMP) of Sarasota, FL, today...
December 09, 2010 18:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Second Quarter FY2011 Financial Results

DURHAM, N.C., Dec. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
November 02, 2010 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Awarded $244,479 Grant Under the Patient Protection and Affordable Care Program

DURHAM, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received nearly $245,000 in a grant under the Patient...
October 20, 2010 08:30 ET | Source: Tenax Therapeutics, Inc.

DERMACYTE(R) Skin Care Products Secure Key Listing on DermStore.com, a Leading Dermatologic and Beauty E-tail Web Site

DURHAM, N.C., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced DERMACYTE® skin care products are now available for purchase...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right